Page last updated: 2024-08-18

pyrazolanthrone and Koch's Disease

pyrazolanthrone has been researched along with Koch's Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lau, AS; Li, JC; Ling, WL; Pong, JC; Wang, LJ1
Cho, JE; Cho, SN; Kim, YS; Lee, H; Park, S1

Other Studies

2 other study(ies) available for pyrazolanthrone and Koch's Disease

ArticleYear
A role for interleukin-17A in modulating intracellular survival of Mycobacterium bovis bacillus Calmette-Guérin in murine macrophages.
    Immunology, 2013, Volume: 140, Issue:3

    Topics: Animals; Anthracenes; Bacterial Load; Cell Line; Cell Survival; Humans; Interleukin-17; Intracellular Space; Macrophages; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mice; Mycobacterium bovis; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphorylation; Tuberculosis

2013
c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) are involved in Mycobacterium tuberculosis-induced expression of Leukotactin-1.
    BMB reports, 2012, Volume: 45, Issue:10

    Topics: Anthracenes; Cell Line, Tumor; Chemokines, CC; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mycobacterium tuberculosis; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridines; Signal Transduction; Tuberculosis; Up-Regulation

2012